Werewolf Therapeutics, Inc.
HOWL
$0.39
$0.001.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.67M | -13.53M | -8.38M | -16.37M | -17.98M |
| Total Depreciation and Amortization | 2.45M | 398.00K | 400.00K | 402.00K | 406.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.02M | 1.07M | 144.00K | 1.96M | 2.49M |
| Change in Net Operating Assets | -2.52M | 1.47M | -3.19M | -1.15M | -75.00K |
| Cash from Operations | 6.63M | -10.60M | -11.02M | -15.16M | -15.16M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 416.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 416.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.41M | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | -- | 2.37M | 3.27M | 388.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.41M | -- | 2.37M | 3.27M | 388.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.37M | -10.60M | -8.66M | -11.88M | -14.78M |